The disclosure relates to pyrido[2,3-d]pyrimidone compounds, to the preparation thereof and to the therapeutic use thereof, wherein said compounds are of general formula (I):
in the form of a base or of an addition salt with an acid which is pharmaceutically acceptable, in the form of hydrates or of solvates, and also in the form of enantiomers, diastereoisomers and a mixture thereof. The disclosure also relates to processes for preparing said compounds, to pharmaceutical compositions containing a compound of general formula (I), and to the therapeutic use of said compounds and compositions.
本发明涉及
吡啶并[2,3-d]
嘧啶酮化合物及其制备和治疗用途,其中所述化合物为一般式(I)的碱式或与药学上可接受的酸的加成盐形式,以及
水合物或溶剂化物形式,还包括对映体、非对映异构体和其混合物形式。本发明还涉及制备所述化合物的方法,含有一般式(I)化合物的制药组合物以及所述化合物和组合物的治疗用途。